Genmab A/S operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genmab A/S with three other
miscellaneous service companies in Europe:
Pharma Mar SA
sales of 180.95 million Euro [US$201.50 million]
of which 62%
was Biotech Sector),
(1.56 billion Swedish Kronor [US$177.89 million]
of which 68%
was LabTech), and
Bachem Holding AG
based in Switzerland
(236.48 million Swiss Francs [US$242.54 million]
of which 89%
was Active Pharmaceutical Ingredients).
Genmab A/S reported sales of 1.82 billion Danish Kroner (US$271.84 million)
December of 2016.
increase of 60.3%
versus 2015, when the company's sales were 1.13 billion Danish Kroner.
Sales at Genmab A/S have increased during each of the previous five years
(and since 2011, sales have increased a total of 418%).